Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19
E. Igarashi, T. Shimada, S. Yazawa, Y. Saga, M. Itamochi, N. Inasaki, Y. Morinaga, K. Oishi, H. Tani
This study examines how trypsin-like proteases affect SARS-CoV-2 infectivity in clinical specimens, finding significant increases for the delta variant compared to omicron.
bioRxiv · Sep 27, 2022 · PreprintMicrobiology